Prof. Steven A. Johnsen, Ph.D.
@profjohnsen
Scientific Director of the Robert Bosch Center for Tumor Diseases. #epigenetics #chromatin #transcription #PancreaticCancer. Associate Editor @NAR_Cancer_EIC
ID: 796426980916858884
https://www.rbct.de/en/node/57 09-11-2016 18:59:23
738 Tweet
787 Followers
222 Following
#GUTOnline paper by Ekstrom et al on "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3Q1wUzF Amro Abdelrahman, MBBS, MS Prof. Steven A. Johnsen, Ph.D. #PancreaticCancer
#GUTOnline paper by Ekstrom et al on "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3Q1wUzF Amro Abdelrahman, MBBS, MS Prof. Steven A. Johnsen, Ph.D. #PancreaticCancer
#GUTOnline paper by Ekstrom et al on "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3Q1wUzF Amro Abdelrahman, MBBS, MS Prof. Steven A. Johnsen, Ph.D. #PancreaticCancer
A fantastic postdoc opportunity available for talented PhD graduates to work in our CRUK funded PhD project. This is a great multidisciplinary project towards prevention breast cancer: jobs.manchester.ac.uk/internal/Job/J… Manchester Breast Centre Manchester Cancer Research Centre UoM Biology, Medicine and Health
Super excited to be back on board as Associate Editor at Bill Dynan - NAR Cancer Editor NAR Cancer is a great place to bring your cancer research papers, where you can be ensured a quality peer review at a top notch academic publisher (with full open access!).
Mayo has played such a special & central role in my life & my career! Since my first visit to the Mayo Clinic when interviewing for the Mayo Clinic Graduate School of Biomedical Sciences in 1999 till 20 years later becoming a staff member and Professor in Mayo Clinic Gastroenterology & Hepatology in 2019, this place remains in my blood.
Super happy to see this commentary in Gut Journal about our recent work!!! Truly one of the most exciting and rewarding projects of my career. So happy to have worked with Tom Ekstrom on this exciting project! #FuturePI #ProudMentor #BoschStiftung gut.bmj.com/content/early/…
#GUTImage from the paper by Ekstrom et al entitled "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3SHMGkH Amro Abdelrahman, MBBS, MS Prof. Steven A. Johnsen, Ph.D. #PancreaticCancer
.Prof. Steven A. Johnsen, Ph.D. and team uncover the transcriptional control and role of glucocorticoid receptor agonists in controlling #PDAC molecular subtype identity. 📚 More in Gut Journal: bit.ly/3FSGxPO
Check out our preprint on #RELA and #RELB function in #PDAC downstream of #canonical and #noncanonical #NFKB signaling. Excellent work from the PhD work of Dr Joana Aggrey-Fynn, who will soon begin her postdoc at Fred Hutch Cancer Center. #pancreaticcancer biorxiv.org/cgi/content/sh…
New in Cell Death & Disease: Targeting FOSL1/RELA suppresses #metastasis in PDAC by disrupting a pro-metastatic transcriptional program. Led by Joana Aggrey-Fynn during her PhD in the Prof. Steven A. Johnsen, Ph.D. lab! 📖 nature.com/articles/s4141… #PancreaticCancer #CancerResearch #PDAC
Informative #GUTVideo by Ekstrom et al on the paper "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/4fhFYwb Paper via: bit.ly/3SHMGkH Prof. Steven A. Johnsen, Ph.D.
Looking forward to another great talk by @ckadoch Kadoch Lab here at the #EpiSociety2025 meeting!